All
Replacing Agent in R-CHOP Regimen Improves Survival in Mantle Cell Lymphoma
October 26th 2018The replacement of vincristine with Velcade (bortezomib) in the R-CHOP regimen for the treatment of transplantation-ineligible patients with newly diagnosed mantle cell lymphoma improved overall survival in a final analysis of the LYM-3002 trial.
Encouraging Preliminary Results in Myelofibrosis Trial Lead to Enhancements in Phase 2
October 26th 2018After seeing encouraging phase 1 results, the phase 2 portion of a clinical trial currently evaluating the efficacy of the BET inhibitor CPI-0610 in patients with myelofibrosis has been enhanced and expanded.
Joining Forces Against Hereditary Risk for Breast and Ovarian Cancer
October 24th 2018After receiving a breast cancer diagnosis “out of the blue” in 1996, Sue Friedman would later come to find out she also has a BRCA2 genetic mutation – a discovery that would lead to the creation of an organization for individuals in a similar situation.
'Bringing Hope Home' After a Cancer Diagnosis
October 24th 2018When Paul Isenberg’s wife, Nicole, was diagnosed with stage 4 Hodgkin lymphoma shortly after the birth of their child, Gabrielle, the couple realized two things: how blessed they were and that some people going through cancer have nobody to turn to.
Aggressive Radiation Therapy Improves Survival in Patients with Metastatic Cancer
October 23rd 2018A high dose of precision radiation could drastically increase the survival rates of patients with metastatic cancer, and double the time patients live without cancer growth, according to study results presented at the 60th Annual Meeting of the American Society for Radiation Oncology.
New Research Says Universal Lynch Syndrome Testing Should Be Expanded
October 22nd 2018While universal screening for Lynch syndrome is currently only recommended for patients with colorectal and endometrial cancers, a new study recently published in The American Journal of Surgical Pathology suggests this for patients with upper tract urothelial carcinoma, too.